Current Issue : July - September Volume : 2021 Issue Number : 3 Articles : 5 Articles
Pharmacist intervention has valuable input to the healthcare system by reducing medication errors, costs of treatment and improving therapeutic outcomes. This study aimed to analyze pharmacists’ interventions during the verification of computerized physician order entry and to determine the association between prescribers’ level and type of prescribing errors. In this cross-sectional, observational study, data collection was carried out over three months starting from 1 January 2020 to 31 March 2020..............
The main user of three dimensional (3D) printing for drug dispensing will be the hospital pharmacist. Yet despite the tremendous amount of research and industrial initiatives, there is no evaluation of the pharmacist’s knowledge and opinion of this technology. The present study aimed to assess knowledge and attitude among pharmacists about 3D printing technology as an innovative dispensing method for personalized medicine and the barriers to implementation in Saudi Arabia..................
Background: Technology is increasingly used to enhance pharmacy education. We sought to evaluate student learning and preparedness for community introductory pharmacy practice experiences (IPPEs) after implementation of “MyDispense” into experiential education. Methods: Both first-year pharmacy students and assigned community IPPE preceptors were eligible.......................
Pharmacists across Canada have varying degrees of ability to prescribe medications depending on their jurisdiction of licensure. The purpose of this study was to the evaluate attitudes, beliefs, and perceptions of independent pharmacist prescribing among health authority- and community-based pharmacists. This prospective, cross-sectional online survey assessed the perceptions of independent pharmacist prescribing of health authority and community pharmacists practising in northern British Columbia (BC), which was defined as within the geographical boundaries of Northern Health....
Fixed dose combination (FDCâ??s) market recently faced a ban on 349 FDCâ??s due to unclear therapeutic rationality. The present study aims to assess the therapeutic rationality of FDCâ??s enlisted in CDSCO list 2020 approved in the last 5 years. List of 119 FDCâ??s approved in India from 2015-2020 by CDSCO was evaluated. In this assessment: WHO EML listing 2019, Efficacy of API, Efficacy of FDC, PKPD, Advantage of reduced dosing and Schedule of FDC was noted. In this evaluation we found that advantage of dose reduction was not offered by any FDC. There were 22.68% FDCâ??s that had chances of increased ADRs due to its API. 81.51% FDCâ??s were found to be rational, 17.65% semi-rational and 0.84% irrational. We reveal that 17.65% FDCâ??s approved in last five years were semi-rational and advantage of dose reduction was not offered by any FDC and 22.68% FDCâ??s had increased chances of ADRâ??s. Therefore, more stringent regulatory control is required by the CDSCO to ascertain therapeutic rationality....
Loading....